This is a teaser from Nick Hodges Early Advantage advisory. He is promoting the stock of a company that has a salt water farm where they grow Keyhole limpets or sea snails. The claim is that the blood of these creatures is very rare and commands extremely high prices, especially from big pharmaceutical companies. He claims that the development of some cancer fighting drugs is dependent upon the blood of these creatures. You can read the rest of his pitch in the teaser. What do ya think Travis?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.